s
Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million
24-07-2024, 14:44
CHICAGO, July 22, 2024 /PRNewswire/ — Valinor Pharma, LLC (“Valinor”) announced today it was purchased by Grünenthal for a total deal value of approximately $250 million in upfront cash consideration. “Today’s announcement recognizes the significant value we have built for our patients and shareholders,” said Todd N. Smith, CEO of Valinor. “This acquisition comes at a […] L'articolo Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million proviene da La Ragione.
CONTINUA A LEGGERE
16
0
0
Guarda anche
Libero Quotidiano
Vanderlande announces acquisition of Siemens Logistics
Libero Quotidiano
Safe Life completes acquisition of Medisol in Europe
Libero Quotidiano
Enstall expands into Germany with the acquisition of Schletter
Libero Quotidiano
One Rock Capital Partners Plans Acquisition of Europe Snacks
La Ragione
17:43
Lavoro, Confagricoltura “Infortuni in calo nel settore agricolo”
La Ragione
17:43